##plugins.themes.academic_pro.article.sidebar##

Download
pdf
Statistic
Read Counter : 64 Download : 71

##plugins.themes.academic_pro.article.main##

Abstract

Inflammatory and degenerative spinal diseases are one of the pressing problems of modern rheumatology due to the high prevalence, frequent incidence of diseases of young and middle-aged men, frequent lesions of internal organs, early disability of patients, socio-economic damage caused to the patient and society. Since 1892, when V.M.Bekhterev described the main clinical manifestations of the disease and suggested that it should be singled out as a separate nosological form, researchers from the leading countries of the world have achieved certain success in studying its nature, mechanisms of development, as well as treatment and rehabilitation of patients. Nevertheless, ankylosing spondylitis (AC), which is regarded as a disease of the musculoskeletal apparatus, affecting mainly young men, remains one of the leading socio-economic problems of our time, leading to disability in working age

Keywords

concentrıc hyper left atrium aortic root

##plugins.themes.academic_pro.article.details##

Creative Commons License

This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.

How to Cite
Rahmonov Sarvar Norpolat ogli. (2023). Clinical and functional characteristics of the cardiovascular system involvement in various variants of ankylosing spondylitis. Texas Journal of Medical Science, 23, 27–36. https://doi.org/10.62480/tjms.2023.vol23.pp27-36
Crossref
Scopus
Google Scholar
Europe PMC

References

  1. Agababova E.R. Spondyloarthritis as an object of promising scientific research in rheumatology. Selected lectures on clinical rheumatology. Ed. V.A. Nasonova, N.V. Bunchuka. M., Medicine, 2001: 74-82.
  2. Badokin V.V. Drug therapy for ankylosing spondylitis (ankylosing spondylitis). Breast cancer. 2004; 20: 1128-1133.
  3. Agababova E.R. Some unclear and unresolved issues of seronegative spondyloarthropathy. Scientific and practical rheumatology. 2001; 4: 10-18.
  4. A.A. Godzenko, I.Yu. Razumova, A.G. Bochkova. CLINICAL EVALUATION OF UVEANA AND ITS VALUE IN THE DIAGNOSTICS OF SPONDYLOARTHRITIS / Scientific and Practical Rheumatolum 2008; 1: 36-48.
  5. Jun Fu & Manyan Wu2 & Yan Liang & Kai Song & Ming Ni1 Yonggang Zhang & Jiying Chen Differences in cardiovascular manifestations between ankylosing spondylitis patients with and without kyphosis // Clin Rheumatol (2016) 35: 2003–2008
  6. Huang Y-P, Wang Y-H, Pan S-L (2013) Increased risk of ischemic heart disease in young patients with newly diagnosed ankylosing spondylitis — a population-based longitudinal follow-up study. Plos ONE 8: e64155
  7. Toussirot E, Bahjaoui-Bouhaddi M, Poncet JC et al (1999) Abnormal autonomic cardiovascular control in ankylosing spondylitis. Ann Rheum Dis 58: 481–487
  8. Yildirir A, Aksoyek S, Calguneri M, Oto A, Kes S (2002) Echocardiographic evidence of cardiac involvement in ankylosing spondylitis. Clin Rheumatol 21: 129–134
  9. Lee-Chiong TL (1998) Pulmonary manifestations of ankylosing spondylitis and relapsing polychondritis. Clin Chest Med 19: 747–758
  10. Malykh, Igor Anatolevich // Condition of the cardiovascular system in patients with ankylosing spondylitis / dissertation of the candidate of medical sciences
  11. , Tyumen
  12. Rheumatology. Clinical lectures / ed. V.V. Badokina. M.: Litterra, 2012. P. 124-150.
  13. Erdes S.F. The history of ankylosing spondylitis: a path from dinosaurs to ASAS // Scientific and Practical Rheumatology. 2014. No. 1 (52). S. 110–113.
  14. Bochkova A.G., Levshakova A.V. / ed. Sh.F. Erdes. Brief guidelines for the examination of patients with spondylitis. M., 2012.S. 39.
  15. Rheumatology: National leadership / ed. E.L. Nasonova, V.A. Nasonova. M .: GEOTAR-Media, 2008. S. 332–348.
  16. Karateev A.E. et al. Clinical recommendations: the use of non-steroidal anti-inflammatory drugs. M .: IMA-press, 2009. S. 7–11, 22–23.
  17. Karateev A.E. Nimesulide in acute chronic pain: an emphasis on safety issues // Farmateka. 2012. No. 6. P. 57–63.
  18. Gaidukova I.Z. and other Integrated use of anti-inflammatory drugs and muscle relaxants in the treatment of patients with ankylosing spondylitis in outpatient practice // Modern rheumatology. 2015. No 3. P. 21–24.
  19. Erdes Sh.F., Volukhin E.V. The value of peripheral joint arthritis in the clinical picture of ankylosing spondylitis // Scientific and Practical Rheumatology. 2014. No. 3 (52). S. 295-299.
  20. Drozdova EA, Tarasova L.N. Diagnosis and treatment of uveitis in rheumatic diseases. M., 2012.S. 96.
  21. Mezenova T.V. et al. Comparative efficacy of infliximab and adalimumab in patients with ankylosing spondylitis. // Scientific and Practical Rheumatology. 2012. No. 2. P. 25-30.
  22. Rebrov A.P., Gaidukova I.Z., Poddubny D.A. Cardiovascular pathology in patients with ankylosing spondylitis. // Scientific and practical rheumatology. 2012. No. 2. P. 100–104.